Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes

Detection of androgen receptor (AR) variant 7 (AR-V7) is emerging as a clinically important biomarker in castrate resistant prostate cancer (CRPC). Detection is possible from tumor tissue, which is often inaccessible in the advanced disease setting. With recent progress in detecting AR-V7 in circula...

Descripción completa

Detalles Bibliográficos
Autores principales: Nimir, Mohammed, Ma, Yafeng, Jeffreys, Sarah A., Opperman, Thomas, Young, Francis, Khan, Tanzila, Ding, Pei, Chua, Wei, Balakrishnar, Bavanthi, Cooper, Adam, De Souza, Paul, Becker, Therese M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678978/
https://www.ncbi.nlm.nih.gov/pubmed/31288377
http://dx.doi.org/10.3390/cells8070688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678978/
https://www.ncbi.nlm.nih.gov/pubmed/31288377
http://dx.doi.org/10.3390/cells8070688

Ejemplares similares